PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 34 filers reported holding PSYCHEMEDICS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,350 | -9.5% | 36,596 | +3.9% | 0.00% | – |
| Q2 2023 | $160,539 | -13.1% | 35,206 | 0.0% | 0.00% | – |
| Q1 2023 | $184,831 | +106738.7% | 35,206 | 0.0% | 0.00% | – |
| Q4 2022 | $173 | -99.9% | 35,206 | -0.3% | 0.00% | – |
| Q3 2022 | $227,000 | +1.8% | 35,304 | 0.0% | 0.00% | – |
| Q2 2022 | $223,000 | -7.1% | 35,304 | +2.0% | 0.00% | – |
| Q1 2022 | $240,000 | 0.0% | 34,618 | 0.0% | 0.00% | – |
| Q4 2021 | $240,000 | -18.4% | 34,618 | 0.0% | 0.00% | – |
| Q3 2021 | $294,000 | +26.7% | 34,618 | +3.8% | 0.00% | – |
| Q2 2021 | $232,000 | +12.6% | 33,341 | 0.0% | 0.00% | – |
| Q1 2021 | $206,000 | +21.9% | 33,341 | 0.0% | 0.00% | – |
| Q4 2020 | $169,000 | +15.0% | 33,341 | 0.0% | 0.00% | – |
| Q3 2020 | $147,000 | -20.5% | 33,341 | -1.3% | 0.00% | – |
| Q2 2020 | $185,000 | -9.3% | 33,797 | 0.0% | 0.00% | – |
| Q1 2020 | $204,000 | -64.8% | 33,797 | -46.8% | 0.00% | – |
| Q4 2019 | $580,000 | +100.7% | 63,576 | +100.0% | 0.00% | – |
| Q3 2019 | $289,000 | -13.7% | 31,788 | -4.7% | 0.00% | – |
| Q2 2019 | $335,000 | -33.3% | 33,369 | -6.9% | 0.00% | – |
| Q1 2019 | $502,000 | -55.8% | 35,847 | -50.0% | 0.00% | – |
| Q4 2018 | $1,136,000 | +55.4% | 71,694 | +84.4% | 0.00% | – |
| Q3 2018 | $731,000 | +7.0% | 38,881 | +9.5% | 0.00% | – |
| Q2 2018 | $683,000 | -6.8% | 35,513 | 0.0% | 0.00% | – |
| Q1 2018 | $733,000 | +13.5% | 35,513 | +12.9% | 0.00% | – |
| Q4 2017 | $646,000 | -43.1% | 31,446 | -49.0% | 0.00% | – |
| Q3 2017 | $1,135,000 | -12.5% | 61,681 | +18.6% | 0.00% | -100.0% |
| Q2 2017 | $1,297,000 | +39.9% | 52,021 | +12.4% | 0.00% | – |
| Q1 2017 | $927,000 | +38.2% | 46,301 | +70.1% | 0.00% | – |
| Q4 2016 | $671,000 | +78.0% | 27,225 | +43.0% | 0.00% | – |
| Q3 2016 | $377,000 | +50.2% | 19,044 | +4.2% | 0.00% | – |
| Q2 2016 | $251,000 | 0.0% | 18,281 | 0.0% | 0.00% | – |
| Q1 2016 | $251,000 | +35.7% | 18,281 | 0.0% | 0.00% | – |
| Q4 2015 | $185,000 | +12.1% | 18,281 | +11.1% | 0.00% | – |
| Q3 2015 | $165,000 | -32.4% | 16,460 | 0.0% | 0.00% | – |
| Q2 2015 | $244,000 | -10.6% | 16,460 | 0.0% | 0.00% | – |
| Q1 2015 | $273,000 | +10.1% | 16,460 | 0.0% | 0.00% | – |
| Q4 2014 | $248,000 | +6.0% | 16,460 | 0.0% | 0.00% | – |
| Q3 2014 | $234,000 | +5.4% | 16,460 | +4.5% | 0.00% | – |
| Q2 2014 | $222,000 | -17.5% | 15,744 | 0.0% | 0.00% | – |
| Q1 2014 | $269,000 | +16.5% | 15,744 | 0.0% | 0.00% | – |
| Q4 2013 | $231,000 | +10.5% | 15,744 | 0.0% | 0.00% | – |
| Q3 2013 | $209,000 | +23.7% | 15,744 | 0.0% | 0.00% | – |
| Q2 2013 | $169,000 | – | 15,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |